Search Results

There are 34023 results for: content related to: Impact of race on biochemical disease recurrence after prostate brachytherapy

  1. You have free access to this content
    The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer

    Cancer

    Volume 119, Issue 3, 1 February 2013, Pages: 681–690, Mark Shilkrut, Gregory S. Merrick, P. William McLaughlin, Matthew H. Stenmark, Eyad Abu-Isa, Sean M. Vance, Howard M. Sandler, Felix Y. Feng and Daniel A. Hamstra

    Version of Record online : 14 AUG 2012, DOI: 10.1002/cncr.27784

  2. You have free access to this content
    The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomes

    BJU International

    Volume 112, Issue 2, July 2013, Pages: E44–E50, Richard G. Stock, Michael Buckstein, Jerry T. Liu and Nelson N. Stone

    Version of Record online : 14 JUN 2013, DOI: 10.1111/bju.12166

  3. You have free access to this content
    The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy

    BJU International

    Volume 114, Issue 6, December 2014, Pages: 865–871, Vimal Krishnan, Guila Delouya, Jean-Paul Bahary, Sandra Larrivée and Daniel Taussky

    Version of Record online : 14 MAR 2014, DOI: 10.1111/bju.12587

  4. A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients

    Medical Physics

    Volume 36, Issue 3, March 2009, Pages: 776–787, Wayne M. Butler, Renee R. Stewart and Gregory S. Merrick

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.3077161

  5. You have free access to this content
    Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

    BJU International

    Volume 109, Issue s1, February 2012, Pages: 22–29, Peter Grimm, Ignace Billiet, David Bostwick, Adam P. Dicker, Steven Frank, Jos Immerzeel, Mira Keyes, Patrick Kupelian, W. Robert Lee, Stefan Machtens, Jyoti Mayadev, Brian J. Moran, Gregory Merrick, Jeremy Millar, Mack Roach, Richard Stock, Katsuto Shinohara, Mark Scholz, Ed Weber, Anthony Zietman, Michael Zelefsky, Jason Wong, Stacy Wentworth, Robyn Vera and Stephen Langley

    Version of Record online : 12 JAN 2012, DOI: 10.1111/j.1464-410X.2011.10827.x

  6. Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years

    BJU International

    John W. Yaxley, Kevin Lah, Julian P. Yaxley, Robert A. Gardiner, Hema Samaratunga and James MacKean

    Version of Record online : 7 OCT 2016, DOI: 10.1111/bju.13659

  7. You have free access to this content
    Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer

    Cancer

    Volume 117, Issue 24, 15 December 2011, Pages: 5579–5588, Mark D. Hurwitz, Susan Halabi, Laura Archer, Lamar S. McGinnis, Michael R. Kuettel, Steven J. DiBiase and Eric J. Small

    Version of Record online : 4 MAR 2011, DOI: 10.1002/cncr.26203

  8. You have free access to this content
    Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

    BJU International

    Volume 104, Issue 11, December 2009, Pages: 1631–1636, Richard G. Stock, Jamie A. Cesaretti, Simon J. Hall and Nelson N. Stone

    Version of Record online : 2 JUN 2009, DOI: 10.1111/j.1464-410X.2009.08661.x

  9. You have free access to this content
    Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity

    Cancer

    Volume 119, Issue 15, 1 August 2013, Pages: 2807–2814, Abhishek A. Solanki and Stanley L. Liauw

    Version of Record online : 30 APR 2013, DOI: 10.1002/cncr.28128

  10. You have free access to this content
    Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy

    BJU International

    Volume 98, Issue 6, December 2006, Pages: 1210–1215, Sara Jane Khaksar, Robert W. Laing, Alastair Henderson, Prasanna Sooriakumaran, David Lovell and Stephen E.M. Langley

    Version of Record online : 11 OCT 2006, DOI: 10.1111/j.1464-410X.2006.06520.x

  11. You have free access to this content
    Long-term potency preservation following brachytherapy for prostate cancer

    BJU International

    Volume 110, Issue 2, July 2012, Pages: 221–225, Kurt M. Snyder, Richard G. Stock, Michael Buckstein and Nelson N. Stone

    Version of Record online : 16 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10800.x

  12. You have free access to this content
    Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma

    Cancer

    Volume 104, Issue 7, 1 October 2005, Pages: 1372–1380, Laurel A. Copeland, Mohamed A. Elshaikh, James Jackson, Louis A. Penner and Willie Underwood III

    Version of Record online : 23 AUG 2005, DOI: 10.1002/cncr.21341

  13. You have free access to this content
    Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer?

    BJU International

    Volume 91, Issue 1, January 2003, Pages: 23–29, G.S. Merrick, W.M. Butler, R.W. Galbreath, J.H. Lief and E. Adamovich

    Version of Record online : 7 JAN 2003, DOI: 10.1046/j.1464-410X.2003.04024.x

  14. You have free access to this content
    Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer

    Cancer

    Volume 118, Issue 8, 15 April 2012, Pages: 2059–2068, Nirav S. Kapadia, Karin Olson, Howard M. Sandler, Felix Y. Feng and Daniel A. Hamstra

    Version of Record online : 26 AUG 2011, DOI: 10.1002/cncr.26498

  15. You have free access to this content
    Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1257–1261, Richard G. Stock, Joshua Berkowitz, Seth R. Blacksburg and Nelson N. Stone

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1464-410X.2012.11057.x

  16. You have free access to this content
    Transperineal interstitial permanent prostate brachytherapy for Japanese prostate cancer patients in Hawaii

    International Journal of Urology

    Volume 11, Issue 9, September 2004, Pages: 728–734, MASASHI MORITA, JOHN L LEDERER, TAKASHI FUKAGAI, MAKOTO SHIMADA and HIDEKI YOSHIDA

    Version of Record online : 16 SEP 2004, DOI: 10.1111/j.1442-2042.2004.00888.x

  17. You have free access to this content
    Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy

    BJU International

    Volume 105, Issue 2, January 2010, Pages: 191–201, Masaki Kimura, Vladimir Mouraviev, Matvey Tsivian, Janice M. Mayes, Takefumi Satoh and Thomas J. Polascik

    Version of Record online : 2 JUL 2009, DOI: 10.1111/j.1464-410X.2009.08715.x

  18. You have free access to this content
    Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val

    BJU International

    Volume 107, Issue 3, February 2011, Pages: 466–470, Veda N. Giri, Karen Ruth, Lucinda Hughes, Robert G. Uzzo, David Y.T. Chen, Stephen A. Boorjian, Rosalia Viterbo and Timothy R. Rebbeck

    Version of Record online : 24 AUG 2010, DOI: 10.1111/j.1464-410X.2010.09522.x

  19. The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy

    Seminars in Surgical Oncology

    Volume 13, Issue 6, November/December 1997, Pages: 454–460, Richard G. Stock and Nelson N. Stone

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2388(199711/12)13:6<454::AID-SSU10>3.0.CO;2-T

  20. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy

    Medical Physics

    Volume 33, Issue 4, April 2006, Pages: 1025–1032, Jian Z. Wang, Nina A. Mayr, Subir Nag, Joseph Montebello, Nilendu Gupta, Nina Samsami and Christos Kanellitsas

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.2181294